Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07CEU
|
||||
| Former ID |
DNC014385
|
||||
| Drug Name |
SOPHORICOSIDE
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [551217] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C21H20O10
|
||||
| Canonical SMILES |
C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)OC4C(C(C(C(O4)CO<br />)O)O)O
|
||||
| InChI |
1S/C21H20O10/c22-7-15-18(26)19(27)20(28)21(31-15)30-11-3-1-9(2-4-11)12-8-29-14-6-10(23)5-13(24)16(14)17(12)25/h1-6,8,15,18-24,26-28H,7H2/t15-,18-,19+,20-,21-/m1/s1
|
||||
| InChIKey |
ISQRJFLLIDGZEP-CMWLGVBASA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Interleukin-5 | Target Info | Inhibitor | [551217] | |
| KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
| Jak-STAT signaling pathway | |||||
| Hematopoietic cell lineage | |||||
| T cell receptor signaling pathway | |||||
| Fc epsilon RI signaling pathway | |||||
| Intestinal immune network for IgA production | |||||
| Asthma | |||||
| Autoimmune thyroid disease | |||||
| Inflammatory bowel disease (IBD) | |||||
| Allograft rejection | |||||
| PANTHER Pathway | Interleukin signaling pathway | ||||
| PathWhiz Pathway | Fc Epsilon Receptor I Signaling in Mast Cells | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.